Your session is about to expire
← Back to Search
Herbal Supplement
Boswellia for Breast Cancer
Phase 1
Waitlist Available
Led By Nancy Klauber-DeMore, MD, FACS
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 6 sections of unstained slides should be obtained. If sufficient slides or tissue is unavailable, the patient will be excluded from the trial.
Females of child-bearing potential must agree to use an approved form of birth control and to have a negative pregnancy test result before and throughout the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 84 days
Awards & highlights
Study Summary
This trial will test whether Boswellia, taken as a pill, can help shrink primary tumors in breast cancer patients.
Who is the study for?
This trial is for adults with breast cancer who are scheduled for surgery, can follow study procedures, and have a tumor at least 1.0 cm large. They must be in good health otherwise, not on certain drugs that affect body transport proteins or blood clotting, and not pregnant or breastfeeding.Check my eligibility
What is being tested?
The trial is testing the effects of Boswellia taken orally on biological changes in primary breast cancer tumors before surgery to remove them.See study design
What are the potential side effects?
Potential side effects of Boswellia may include digestive issues like nausea or diarrhea, allergic reactions, and possible interactions with other medications affecting liver enzymes involved in drug metabolism.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can provide at least 6 unstained slides for testing.
Select...
I agree to use birth control and will provide negative pregnancy tests before and during the study.
Select...
I am fully active or restricted in physically strenuous activity but can do light work.
Select...
I am 18 years old or older.
Select...
My breast cancer is confirmed and the tumor is at least 1 cm big.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 84 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 84 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in tumor proliferation rate
Secondary outcome measures
Changes in tumors analyzed through immunohistochemistry
Number of adverse events reported
Trial Design
1Treatment groups
Experimental Treatment
Group I: BoswelliaExperimental Treatment1 Intervention
Boswellia will be given at 800mg by mouth three times a day, immediately after each meal. Boswellia will be given from the time surgical resection is scheduled until the night before surgical resection.
Find a Location
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
932 Previous Clinical Trials
7,394,344 Total Patients Enrolled
10 Trials studying Breast Cancer
603 Patients Enrolled for Breast Cancer
Nancy Klauber-DeMore, MD, FACSPrincipal InvestigatorMedical University of South Carolina
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently taking medication that inhibits 5-lipoxygenase.I am not taking medication that affects certain drug transporters.I am currently taking blood thinners or medication to prevent blood clots.I can provide at least 6 unstained slides for testing.I understand the risks and benefits of the study and can give my consent.I have severe kidney disease or moderate liver problems.I have a blockage in my intestines.I am currently receiving chemotherapy or hormone therapy before surgery.I agree to use birth control and will provide negative pregnancy tests before and during the study.I am fully active or restricted in physically strenuous activity but can do light work.I am 18 years old or older.I have a history of blood clotting or blood disorders.I am having emergency surgery.My surgery at MUSC is scheduled between 5 and 56 days from the start of the trial.I can follow the study's requirements and attend all follow-ups.My breast cancer is confirmed and the tumor is at least 1 cm big.I have had or currently have deep vein thrombosis.My blood and organs are functioning well.
Research Study Groups:
This trial has the following groups:- Group 1: Boswellia
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this clinical trial actively searching for participants?
"According to the details shared on clinicaltrials.gov, this particular medical trial is no longer recruiting patients as of August 9th 2022. First posted in 2017, it has since been supplanted by 2,600 other studies that are currently enrolling participants."
Answered by AI
What risks does Boswellia pose to individuals undergoing treatment?
"Due to the limited clinical evidence available, Boswellia's safety was rated at 1 on a scale of 1-3. As this is still in phase one of testing, both efficacy and safety have yet to be confirmed."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger